Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Daiichi Sankyo
Cantor Fitzgerald
US Department of Justice

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065130

« Back to Dashboard

NDA 065130 describes SUPRAX, which is a drug marketed by Lupin Ltd, Lederle, and Lupin Pharms, and is included in eight NDAs. It is available from five suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the SUPRAX profile page.

The generic ingredient in SUPRAX is cefixime. There are fourteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefixime profile page.
Summary for 065130
Applicant:Lupin Pharms
Formulation / Manufacturing:see details
Pharmacology for NDA: 065130
Medical Subject Heading (MeSH) Categories for 065130
Suppliers and Packaging for NDA: 065130
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUPRAX cefixime TABLET;ORAL 065130 ANDA Lupin Pharmaceuticals, Inc. 27437-201 27437-201-01 100 TABLET in 1 BOTTLE (27437-201-01)
SUPRAX cefixime TABLET;ORAL 065130 ANDA Lupin Pharmaceuticals, Inc. 27437-201 27437-201-08 50 TABLET in 1 BOTTLE (27437-201-08)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength400MG
Approval Date:Feb 12, 2004TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Farmers Insurance
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.